controlled release for RLS,
Showing 1 - 25 of 4,998
RLS Trial in United States (HORIZANT 300 mg, HORIZANT 600 mg, Placebo)
Recruiting
- RLS
- HORIZANT 300 mg
- +2 more
-
Redwood City, California
- +11 more
Jun 7, 2021
RLS Trial in United States (HORIZANT 300 mg)
Withdrawn
- RLS
- HORIZANT 300 mg
-
Redwood City, California
- +3 more
Apr 7, 2021
RLS Trial in United States (HORIZANT 600 mg)
Recruiting
- RLS
- HORIZANT 600 mg
-
Redwood City, California
- +10 more
Jun 7, 2021
Restless Legs Syndrome Trial in Karabük (progressive muscle relaxation exercise training)
Completed
- Restless Legs Syndrome
- progressive muscle relaxation exercise training
-
Karabük, TurkeyKarabük Training and Research Hospital
Mar 21, 2022
RLS Trial (Massage)
Not yet recruiting
- RLS
- Massage
- (no location specified)
Feb 21, 2022
Restless Legs Syndrome, Restless Legs Syndrome (RLS) Trial in United States (Ropinirole IR 1 mg, Ropinirole IR 2 mg, Ropinirole
Completed
- Restless Legs Syndrome
- Restless Legs Syndrome (RLS)
- Ropinirole IR 1 mg
- +7 more
-
Laguna Hills, California
- +29 more
Nov 27, 2018
Restless Legs Syndrome (RLS) Trial in United States (Injectafer, Placebo)
Restless Leg Syndrome Trial in Tampa (Gabapentin immediate release, Gabapentin enacarbil extended release)
Terminated
- Restless Leg Syndrome
- Gabapentin immediate release
- Gabapentin enacarbil extended release
-
Tampa, FloridaUniversity of South Florida
Nov 8, 2021
Gut Microbiota and Bacterial Translocation in Restless Legs
Not yet recruiting
- Restless Legs Syndrome
- Fecal collection
- +3 more
-
Montpellier, FranceUnité des troubles du sommeil et de l'éveil-Centre de référence
Aug 9, 2023
Patent Foramen Ovale Trial in Nanjing (SnowyTM PFO closure system, Cardi-o-fix PFO occluder)
Not yet recruiting
- Patent Foramen Ovale
- SnowyTM PFO closure system
- Cardi-o-fix PFO occluder
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Apr 29, 2022
Moderate to Severe Idiopathic RLS With Daytime Symptoms Trial in Kassel, Barcelona, Goteborg (Oxycodone naloxone prolonged
Completed
- Moderate to Severe Idiopathic RLS With Daytime Symptoms
- Oxycodone naloxone prolonged release tablets (OXN PR)
- Placebo (PLA)
-
Kassel, Germany
- +2 more
Oct 19, 2018
Restless Legs Syndrome Trial in Bordeaux (other, behavioral, device)
Not yet recruiting
- Restless Legs Syndrome
- Clinical assessment
- +3 more
-
Bordeaux, FranceCHU de Bordeaux - Neurophysiologie Clinique de l'Enfant et de l'
Jan 13, 2023
Electrolyte Imbalance, Kidney Transplant; Complications Trial (Ringer's Lactate Crystalloid Solutions, Normal saline)
Not yet recruiting
- Electrolyte Imbalance
- Kidney Transplant; Complications
- Ringer's Lactate Crystalloid Solutions
- Normal saline
- (no location specified)
Sep 7, 2023
Hypoxic-Ischemic Encephalopathy Trial (RLS-0071, Placebo)
Not yet recruiting
- Hypoxic-Ischemic Encephalopathy
- RLS-0071
- Placebo
- (no location specified)
Mar 17, 2023
Restless Legs Syndrome Trial in Columbia (Horizant)
Completed
- Restless Legs Syndrome
-
Columbia, MissouriUniversity of Missouri Health Care
Feb 1, 2022
European Training Program for Robotic Liver Surgery (LIVEROBOT)
Not yet recruiting
- Liver Diseases
- +6 more
- European Multicentre Training Program for Robotic Liver Surgery
- (no location specified)
Feb 8, 2023
Restless Legs Syndrome in People With Neuromyelitis Optica
Recruiting
- Neuromyelitis Optica
- Restless Legs Syndrome
- assessments
-
İzmir, TurkeyDokuz Eylul University
Oct 6, 2022
Restless Legs Syndrome, Pregnancy Related, Sleep Disorder Trial in Kayseri (Compression stocks, Knee socks)
Completed
- Restless Legs Syndrome
- +2 more
- Compression stocks
- Knee socks
-
Kayseri, Turkey
- +1 more
Mar 21, 2023
Restless Legs Syndrome, End Stage Renal Disease Trial (Ascorbic acid, Tocopherol, Placebo capsule)
Not yet recruiting
- Restless Legs Syndrome
- End Stage Renal Disease
- Ascorbic acid
- +2 more
- (no location specified)
Aug 22, 2022
Healthy Trial in Hannover (RLS-0071 (10 mg/kg intravenously every 8 hours for total of 3 doses), RLS-0071 (loading dose of 120
Recruiting
- Healthy
- RLS-0071 (10 mg/kg intravenously every 8 hours for total of 3 doses)
- +2 more
-
Hannover, GermanyFraunhofer Institute for Toxicology and Experimental Medicine (I
May 25, 2022
Clinical Features Associated With Restless Legs Syndrome.
Recruiting
- Restless Legs Syndrome
-
Montpellier, FranceUhmontpellier
Sep 18, 2021
Muscle Disorder Trial in Alexandria (stretching exercises, thermotherapy)
Completed
- Muscle Disorder
- stretching exercises
- thermotherapy
-
Alexandria, EgyptFaculty of Nursing
Feb 18, 2022
End Stage Renal Disease, Restless Legs Syndrome Trial in Halifax, Hamilton, Ottawa (Gabapentin, Ropinirole, Placebo Gabapentin)
Completed
- End Stage Renal Disease
- Restless Legs Syndrome
- Gabapentin
- +3 more
-
Halifax, Nova Scotia, Canada
- +2 more
Sep 19, 2022